IndraLab

Statements


| 1

eidos
"To get prepared for ataxin-3 lowering therapies in further clinical trials , our study aimed to establish sensitive methods to measure total full-length and polyQ-expanded ataxin-3 protein in PBMCs , an easily accessible human biomaterial ."